NEOFASTER BIO
COST RECOVERY PROGRAMME FOR BLOOD BANKS
REIMBURSEMENT
Surplus platelets are purchased, helping public banks recover costs. from otherwise discarded materials.
REPURPOSING
Extend biological material shelf life; develop innovative pharmaceuticals through lyophilisation.
IMPROVE OUTCOMES
Enhance patient health by using repurposed pharmaceuticals, advancing regenerative medicine.
PHARMACEUTICAL DRUG PRODUCT
Neofaster Bio uses cord and adult blood platelet concentrates as a starting material. The platelet concentrates are obtained using the bionest system and following Whitenest’s procedure validated by the study group Multicord 12.
Is obtained by pooling cord blood platelet concentrates to even out individual differences resulting in a fully standardized drug product
Volume: 5 mL
Packaging: Single Dose
Shelf life: 2 years
Is obtained by pooling buffy coat platelet concentrates to even out individual differences resulting in a fully standardized drug product
Volume: 5 mL
Packaging: Single Dose
Shelf life: 2 years
LYSADERM
The journey to marketing authorisation for a dermatological cream aimed at treating diabetic foot ulcers based on the Neofaster Bio
